VitaDAO បិទមូលនិធិចំនួន $4.1M ជាមួយនឹងក្រុមហ៊ុន Pfizer Ventures សម្រាប់ការស្រាវជ្រាវយូរអង្វែង

VitaDAO was started in 2021 by Tyler Golato of decentralized biotech protocol ម៉ូលេគុល to fund longevity research. According to the organization, it boasts a community of over 9,000 “enthusiasts, researchers and contributors,” and deployed over $3.5 million to projects researching diseases of aging, cellular biology and repairing age-related damage to the body in 2022.

Source: https://www.coindesk.com/web3/2023/01/30/vitadao-closes-41m-funding-round-with-pfizer-ventures-for-longevity-research/?utm_medium=referral&utm_source=rss&utm_campaign=headlines